Mico BioMed Co. Ltd. (214610) - Total Liabilities

Latest as of September 2025: ₩7.88 Billion KRW ≈ $5.34 Million USD

Based on the latest financial reports, Mico BioMed Co. Ltd. (214610) has total liabilities worth ₩7.88 Billion KRW (≈ $5.34 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Mico BioMed Co. Ltd.'s assets to evaluate the company's liquid asset resilience ratio.

Mico BioMed Co. Ltd. - Total Liabilities Trend (2015–2024)

This chart illustrates how Mico BioMed Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 214610 asset base.

Mico BioMed Co. Ltd. Competitors by Total Liabilities

The table below lists competitors of Mico BioMed Co. Ltd. ranked by their total liabilities.

Company	Country	Total Liabilities
Nafpaktos Textile Industry S.A AT:NAYP	Greece	€18.91 Million
Wegmans Holdings Berhad KLSE:0197	Malaysia	RM46.45 Million
Korea Plasma Technology U Co.Ltd KQ:054410	Korea	₩39.75 Billion
Callan JMB Inc. Common Stock NASDAQ:CJMB	USA	$3.77 Million
Serica Energy PLC LSE:SQZ	UK	GBX1.50 Billion
Arita Prima Indonesia Tbk JK:APII	Indonesia	Rp232.80 Billion
Embelton Ltd AU:EMB	Australia	AU$14.14 Million
Medience Co. LTD KQ:014100	Korea	₩42.33 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down Mico BioMed Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 214610 net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.31	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.23	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mico BioMed Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mico BioMed Co. Ltd. (2015–2024)

The table below shows the annual total liabilities of Mico BioMed Co. Ltd. from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩28.58 Billion ≈ $19.37 Million	+14.38%
2023-12-31	₩24.99 Billion ≈ $16.93 Million	-37.24%
2022-12-31	₩39.82 Billion ≈ $26.98 Million	+9.34%
2021-12-31	₩36.42 Billion ≈ $24.68 Million	+142.82%
2020-12-31	₩15.00 Billion ≈ $10.16 Million	-37.53%
2019-12-31	₩24.01 Billion ≈ $16.27 Million	+30.16%
2018-12-31	₩18.45 Billion ≈ $12.50 Million	+41.64%
2017-12-31	₩13.02 Billion ≈ $8.83 Million	+130.32%
2016-12-31	₩5.65 Billion ≈ $3.83 Million	+0.74%
2015-12-31	₩5.61 Billion ≈ $3.80 Million	--

About Mico BioMed Co. Ltd.

KQ:214610 Korea Publishing

Market Cap

$13.00 Million

₩19.18 Billion KRW

Market Cap Rank

#26467 Global

#1998 in Korea

Share Price

₩2290.00

Change (1 day)

-2.35%

52-Week Range

₩2255.00 - ₩4735.00

All Time High

₩12100.26